The News
Catch the latest updates as CTMC drives innovation in cell therapy to accelerate development and manufacturing
to impact patients sooner
Press Releases
KSQ Therapeutics + CTMC Announce Strategic Collaboration to Accelerate the Development of Novel Engineered Tumor Infiltrating Lymphocyte (eTIL®) Therapies for the Treatment of Solid Tumors
Lexington, Mass., September 6, 2023 — KSQ Therapeutics, Inc. ("KSQ"), a clinical-stage biotechnology company developing cancer therapies using its...
CTMC MARKS ONE YEAR OF ACCELERATING LIFE-SAVING CELL THERAPIES TO PATIENTS
Leading Cell Therapy Developer to Attend BIO in Boston, June 5-8 HOUSTON (June 5, 2023) — CTMC, a joint venture between MD Anderson Cancer Center...
Invectys and CTMC announce FDA clearance of IND application for anti-HLA-G CAR-T cell therapy
HOUSTON, Texas, Dec 19, 2022 – Invectys, Inc. and CTMC, a joint venture between MD Anderson Cancer Center and National Resilience, Inc., today...
Recent News
BioProcess International eBook: Autologous Cell Therapies — Shoring Up Supply Chains for Scalability
This eBook collects perspectives from around the cell-therapy industry on ways to ameliorate the scale-related and logistical limitations of...
Tying Advanced Biomanufacturing to a Clinic
By Gail Dutton Cell therapy manufacturers approach autologous therapy manufacturing in multiple ways, with point-of-care manufacturing, academic...
Opinion: To Scale Cell Therapy, Regional Manufacturing Is the Smart Middle Path
By Jane Koo The patient-specific nature of autologous cell therapies presents unique challenges that can best be addressed by a middle path between...
Navigating cell therapy’s maze of risks
How a strategic, collaborative approach can accelerate product development and bring cell therapies to patients Jason Bock, Ph.D. Access the...
San Jac interns set standard for biomanufacturing collaboration
Jacquelynn Conger PASADENA, Texas – A transformative partnership between San Jacinto College and CTMC is producing powerful...
What are the biggest roadblocks still standing in the way of cell and gene therapy commercialization?
Pharma's Almanac / PAO-09-25-NI-01 Access the article: Pharma's Almanac
HealthBiz Podcast: Delivering on the Promise of CAR T Cell Therapy w/ Dr. Jason Bock
Access the podcast: HealthBiz with David Williams
APAC is dynamic and rapidly evolving, with tremendous growth in R&D and attractive market conditions
| Opinion | By Dr Manbeena Chawla With cell and gene therapy (CGT) representing a major advancement in medical...
Inside CTMC: Innovating cell therapy development from patient to clinic
Cell therapy has emerged as one of the most promising frontiers in biopharmaceutical innovation, offering potential cures for diseases once...